iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/36769694/
Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 29;12(3):1046.
doi: 10.3390/jcm12031046.

Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases

Ghizlene Lahlou  1   2 , Charlotte Calvet  1   3 , Marie Giorgi  1 , Marie-José Lecomte  1 , Saaid Safieddine  1   4
Affiliations
Review

Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases

Ghizlene Lahlou et al. J Clin Med. .

Abstract

Hearing loss, the most common human sensory defect worldwide, is a major public health problem. About 70% of congenital forms and 25% of adult-onset forms of deafness are of genetic origin. In total, 136 deafness genes have already been identified and there are thought to be several hundred more awaiting identification. However, there is currently no cure for sensorineural deafness. In recent years, translational research studies have shown gene therapy to be effective against inherited inner ear diseases, and the application of this technology to humans is now within reach. We provide here a comprehensive and practical overview of current advances in gene therapy for inherited deafness, with and without an associated vestibular defect. We focus on the different gene therapy approaches, considering their prospects, including the viral vector used, and the delivery route. We also discuss the clinical application of the various strategies, their strengths, weaknesses, and the challenges to be overcome.

Keywords: AAV; gene therapy; hearing impairment; vestibular defect.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Route of administration for inner ear gene therapy. Routes of administration evaluated in mouse models (left panel), and potential delivery routes in humans (surgical view through the middle ear cavities, right panel). The most widely used delivery route is injection through the round window membrane (1), which is possible in both mice and humans, followed by the posterior semicircular canal (SCC, 2) in mice, which is potentially equivalent to a lateral SCC injection (3) in humans. Other techniques that have been evaluated in mice include injection into the endolymphatic sac (4) and cochleostomy (5). Injection through the oval window (6) is possible in humans, but not in mice, due to the persistence of the stapedial artery in rodents.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Smith R.J.H., Bale J.F., White K.R. Sensorineural Hearing Loss in Children. Lancet. 2005;365:879–890. doi: 10.1016/S0140-6736(05)71047-3. - DOI - PubMed
    1. Haile L.M., Kamenov K., Briant P.S., Orji A.U., Steinmetz J.D., Abdoli A., Abdollahi M., Abu-Gharbieh E., Afshin A., Ahmed H., et al. Hearing Loss Prevalence and Years Lived with Disability, 1990–2019: Findings from the Global Burden of Disease Study 2019. Lancet. 2021;397:996–1009. doi: 10.1016/S0140-6736(21)00516-X. - DOI - PMC - PubMed
    1. François M., Boukhris M., Noel-Petroff N. Schooling of Hearing-Impaired Children and Benefit of Early Diagnosis. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2015;132:251–255. doi: 10.1016/j.anorl.2015.08.026. - DOI - PubMed
    1. Lin F.R., Yaffe K., Xia J., Xue Q.L., Harris T.B., Purchase-Helzner E., Satterfield S., Ayonayon H.N., Ferrucci L., Simonsick E.M. Hearing Loss and Cognitive Decline in Older Adults. JAMA Intern. Med. 2013;173:293–299. doi: 10.1001/jamainternmed.2013.1868. - DOI - PMC - PubMed
    1. Cunningham L.L., Tucci D.L. Hearing Loss in Adults. N. Engl. J. Med. 2017;377:2465–2473. doi: 10.1056/NEJMra1616601. - DOI - PMC - PubMed

LinkOut - more resources